++
A superficial infection of skin secondary to either S. aureus or group A β-hemolytic streptococci. The primary lesion is a superficial pustule that ruptures and forms a “honey-colored” crust. Tense bullae are associated with S. aureus infections (bullous impetigo). Lesions may occur anywhere but commonly involve the face. Impetigo and furunculosis (painful erythematous nodule, or boil) have gained prominence because of increasing incidence of CA-MRSA.
++
TREATMENT: IMPETIGO
Gentle debridement of adherent crusts with soaks and topical antibiotics; appropriate oral antibiotics depending on organism.
++
Superficial cellulitis, most commonly on face, characterized by a bright red, sharply demarcated, intensely painful, warm plaque. Because of superficial location of infection and associated edema, surface of plaque may exhibit a peau d’orange (orange peel) appearance. Most commonly due to infection with group A β-hemolytic streptococci, occurring at sites of trauma or other breaks in skin.
++
TREATMENT: ERYSIPELAS
Appropriate antibiotics depending on organism.
++
Recurrent eruption characterized by grouped vesicles on an erythematous base that progress to erosions; often secondarily infected with staphylococci or streptococci (See Also Chap. 99). Infections frequently involve mucocutaneous surfaces around the oral cavity, genitals, or anus. Can also cause severe visceral disease including esophagitis, pneumonitis, encephalitis, and disseminated herpes simplex virus infection. Tzanck preparation of an unroofed early vesicle reveals multinucleated giant cells. Confirmed by detection of virus, viral antigen, or viral DNA in scrapings from lesions.
++
TREATMENT: HERPES SIMPLEX
Will differ based on disease manifestations and level of immune competence (Chap. 99); appropriate antibiotics for secondary infections, depending on organism.
++
Eruption of grouped vesicles on an erythematous base usually limited to a single dermatome (“shingles”); disseminated lesions can also occur, especially in immunocompromised pts (See Also Chap. 99). Tzanck preparation reveals multinucleated giant cells; indistinguishable from herpes simplex except by culture. Detection of varicella zoster virus DNA by PCR is confirmatory but of limited availability. Postherpetic neuralgia, lasting months to years, may occur, especially in the elderly.
++
TREATMENT: HERPES ZOSTER
Will differ based on disease manifestations and level of immune competence (Chap. 99).
+++
DERMATOPHYTE INFECTION
++
Skin fungus, may involve any area of body; due to infection of stratum corneum, nail plate, or hair. Appearance may vary from mild scaliness to florid inflammatory dermatitis. Common sites of infection include the foot (tinea pedis), nails (tinea unguium), groin (tinea cruris), or scalp (tinea capitis). Classic lesion of tinea corporis (“ringworm”) is an erythematous papulosquamous patch, often with central clearing and scale along peripheral advancing border. Hyphae are often seen on KOH preparation, although tinea capitis and tinea corporis may require culture or biopsy.
++
TREATMENT: DERMATOPHYTE INFECTION
Depends on affected site and type of infection. Topical imidazoles, triazoles, and allylamines may be effective. Haloprogin, undecylenic acid, ciclopirox olamine, and tolnaftate are also effective, but nystatin is not active against dermatophytes. Griseofulvin, 500 mg/d, if systemic therapy required. Itraconazole or terbinafine may be effective for nail infections.
++
Fungal infection caused by a related group of yeasts. Manifestations may be localized to the skin or rarely systemic and life-threatening. Predisposing factors include diabetes mellitus, cellular immune deficiencies, and HIV (Chap. 105). Frequent sites include the oral cavity, chronically wet macerated areas, around nails, intertriginous areas. Diagnosed by clinical pattern and demonstration of yeast on KOH preparation or culture.
++
TREATMENT: CANDIDIASIS
(See Also Chap. 106) Removal of predisposing factors; topical nystatin or azoles; systemic therapy reserved for immunosuppressed pts, unresponsive chronic or recurrent disease; vulvovaginal candidiasis may respond to a single dose of fluconazole, 150 mg.
++
Cutaneous neoplasms caused by human papilloma viruses (HPVs). Typically dome-shaped lesions with irregular, filamentous surface. Propensity for the face, arms, and legs; often spread by shaving. HPVs are also associated with genital or perianal lesions and play a role in the development of cancer of the uterine cervix and anogenital skin (Chap. 83).
++
TREATMENT: WARTS
Cryotherapy with liquid nitrogen, keratinolytic agents (salicylic acid). For genital warts, application of podophyllin solution is effective but can be associated with marked local reactions; topical imiquimod also has been used. HPV vaccine reduces the incidence of anogenital and cervical carcinoma.